PULMATRIX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.04 USD | -1.92% |
|
+2.53% | +9.68% |
| Mar. 28 | Pulmatrix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 13 | Pulmatrix, Inc. Approves Termination of Margaret Wasilewski as Chief Medical Officer | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 11.84 | 17.2 | 40.94 | 24.61 | 14.12 | 6.793 |
| Enterprise Value (EV) 1 | 9.28 | -5.57 | 11.03 | -26.94 | -20.65 | -3.624 |
| P/E ratio | -0.48 x | -0.7 x | -1.77 x | -1.01 x | -0.71 x | -0.48 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 77.4 x | 2.17 x | 3.24 x | 4.76 x | 2.33 x | 0.93 x |
| EV / Revenue | 60.7 x | -0.7 x | 0.87 x | -5.21 x | -3.4 x | -0.5 x |
| EV / EBITDA | -0.46 x | 0.42 x | -1.14 x | 1.64 x | 1.1 x | 0.25 x |
| EV / FCF | -0.99 x | -7.24 x | -1.68 x | 2.19 x | 2.13 x | 0.5 x |
| FCF Yield | -101% | -13.8% | -59.4% | 45.6% | 47% | 201% |
| Price to Book | 1 x | 1.56 x | 1.86 x | 0.61 x | 0.45 x | 0.38 x |
| Nbr of stocks (in thousands) | 247 | 1,000 | 1,720 | 2,812 | 3,639 | 3,652 |
| Reference price 2 | 48.02 | 17.20 | 23.80 | 8.752 | 3.880 | 1.860 |
| Announcement Date | 2/19/19 | 3/26/20 | 3/23/21 | 3/29/22 | 3/30/23 | 3/28/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.153 | 7.91 | 12.63 | 5.169 | 6.071 | 7.298 |
| EBITDA 1 | -20.1 | -13.24 | -9.647 | -16.42 | -18.78 | -14.61 |
| EBIT 1 | -20.33 | -13.42 | -9.862 | -16.59 | -18.95 | -14.74 |
| Operating Margin | -13,288.24% | -169.71% | -78.06% | -320.95% | -312.09% | -201.97% |
| Earnings before Tax (EBT) 1 | -20.56 | -20.6 | -19.31 | -20.17 | -18.84 | -14.12 |
| Net income 1 | -20.56 | -20.6 | -19.31 | -20.17 | -18.84 | -14.12 |
| Net margin | -13,439.87% | -260.38% | -152.83% | -390.23% | -310.26% | -193.49% |
| EPS 2 | -99.67 | -24.62 | -13.43 | -8.627 | -5.463 | -3.867 |
| Free Cash Flow 1 | -9.396 | 0.769 | -6.554 | -12.28 | -9.696 | -7.296 |
| FCF margin | -6,141.26% | 9.72% | -51.87% | -237.64% | -159.71% | -99.97% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 2/19/19 | 3/26/20 | 3/23/21 | 3/29/22 | 3/30/23 | 3/28/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1.069 | 0.456 | 1.16 | 1.331 | 1.872 | 1.708 | 1.844 | 1.753 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -4.613 | -4.043 | -4.963 | -4.559 | -5.1 | -4.325 | -3.991 | -3.939 |
| Operating Margin | -431.52% | -886.62% | -427.84% | -342.52% | -272.44% | -253.22% | -216.43% | -224.7% |
| Earnings before Tax (EBT) 1 | -8.184 | -4.031 | -4.973 | -4.595 | -5.052 | -4.216 | -3.816 | -3.774 |
| Net income 1 | -8.184 | -7.228 | -4.973 | -4.595 | -5.052 | -4.216 | -3.816 | -3.774 |
| Net margin | -765.58% | -1,585.09% | -428.71% | -345.23% | -269.87% | -246.84% | -206.94% | -215.29% |
| EPS 2 | -3.000 | -2.430 | -1.510 | -1.360 | -1.450 | -1.140 | -1.040 | -1.030 |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 11/10/21 | 3/29/22 | 5/12/22 | 8/10/22 | 11/10/22 | 3/30/23 | 8/10/23 | 11/9/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 2.56 | 22.8 | 29.9 | 51.6 | 34.8 | 10.4 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -9.4 | 0.77 | -6.55 | -12.3 | -9.7 | -7.3 |
| ROE (net income / shareholders' equity) | -187% | -180% | -113% | -57.2% | -48% | -57.5% |
| ROA (Net income/ Total Assets) | -82.8% | -33% | -16.6% | -21.4% | -23.7% | -24.6% |
| Assets 1 | 24.84 | 62.38 | 116.3 | 94.26 | 79.35 | 57.41 |
| Book Value Per Share 2 | 48.00 | 11.00 | 12.80 | 14.40 | 8.550 | 4.930 |
| Cash Flow per Share 2 | 10.40 | 23.40 | 17.50 | 16.70 | 9.790 | 5.250 |
| Capex 1 | 0.02 | 0.06 | 0.28 | 0.14 | 0.09 | 0.68 |
| Capex / Sales | 12.42% | 0.73% | 2.22% | 2.79% | 1.42% | 9.26% |
| Announcement Date | 2/19/19 | 3/26/20 | 3/23/21 | 3/29/22 | 3/30/23 | 3/28/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +9.68% | 7.45M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
- Stock Market
- Equities
- PULM Stock
- Financials Pulmatrix, Inc.
